Member Info for busymumof3

All please be careful of CPX as a holder, without a fantastic RNS, its a very good pump and dump share, so peeps don't get caught out with others agendas. The company has amazing potential, but that potential has to come to fruition.

Benchmarking new platforms is critical to ensure data is reliable, leading the authors to use Genome in a Bottle samples to confirm that nanopore technology can accurately detect genetic variants. This included structural variants (SVs), copy number variants (CNVs), and short tandem repeats (STRs), in addition to the single nucleotide variants (SNVs) and small indels possible with short-read methods. They then performed retrospective nanopore sequencing of research samples from individuals alongside the use of a clinically approved short-read diagnostic tool and obtained concurrent results. Therefore, in the future, nanopore sequencing could provide a faster and more in-depth genetic analysis, particularly for STR expansion conditions, such as Fragile X syndrome and Huntington’s disease.

Streamline your human variation analysis with our end-to-end protocol

Achieve high-quality and reproducible results with our complete end-to-end human variation protocol utilising the Ligation Sequencing Kit V14 and the EPI2ME wf-human-variation data analysis workflow. This protocol includes step-by-step guidance to enhance efficiency and provide informative results from the laboratory bench, starting with gDNA extraction from blood and finishing with user-friendly data analysis.

The rapid detection of a neonatal unit outbreak of a wild-type Klebsiella variicola using decentralised Oxford Nanopore sequencing

Klebsiella variicola, often misidentified as Klebsiella pneumoniae, can cause serious blood infections. A neonatal unit reported four cases of K. pneumoniae, but nanopore sequencing data showed that three cases were actually K. variicola, of which two were a new strain. Nanopore sequencing provided species-level identification within 48 hours, enabling infection control measures to halt the outbreak.

Jack I haven't been able to get a buy price on Halifax all morning, can anyone get a buy price?

And the seller that keeps selling the 5 million trenches, lets hope they are all out now.

Ian not everyone that post on here has an agenda, I don't... your pay your money and take a chance to improve your life, everyone is over the age of 18 and should take responsibility for their actions.

.2306 to sell and .2325 to buy

Looks like we have a seller off loading 5million at a time, so the sp could drop more today

Investdonk I can't buy, can anyone else get a buy price?

the stock Market is just a game that small investors can win at.

WTF back to .25 to buy now....how insane

Happy with that update, lets see how the market reacts

Buy .2488 up to £10k then NT, sell .246

looks like the MMs may take this up with a few more buys, just like last week

.2541 to sell and .2568 to buy up to £10k then NT for anything higher

Broom have been in to many shares that have left shareholders with zero value, while they BOD have lined their pockets and promised great wealth to its shareholders.

Its always good to remember a profit is a profit.

.261 to sell and .2637 to buy, if this hits .25 will we see buyers coming back?

mark and for the record if this gets to your buy in level I have £15k in my trading pot that I will be happy to put in here.

.2655 to sell and .267 to buy

Am sure if it goes to .25 all the traders will jump in

A hybrid genome assembly of the endangered aye-aye (Daubentonia madagascariensis)

Previous aye-aye reference genomes were incomplete, fragmented, and contained no protein-coding gene annotations due to legacy short-read sequencing. Here the authors used nanopore sequencing to produce a fully annotated chromosome-level de novo assembly. They identified 18,858 protein-coding genes, similar to the number of genes found in lemurs, allowing comparisons to be drawn with other primates for evolutionary research.

New uncle AIM it a cesspit, the regulators are paid by these companies, so they don't look out for shareholders